» Articles » PMID: 27852420

Prisoners Co-infected with Tuberculosis and HIV: a Systematic Review

Overview
Journal J Int AIDS Soc
Date 2016 Nov 18
PMID 27852420
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Almost from the beginning of the HIV epidemic in 1981, an association with tuberculosis (TB) was recognized. This association between HIV and TB co-infection has been particularly evident amongst prisoners. However, despite this, few studies of TB in prisons have stratified results by HIV status. Given the high prevalence of HIV-positive persons and TB-infected persons in prisons and the documented risk of TB in those infected with HIV, it is of interest to determine how co-infection varies amongst prison populations worldwide. For this reason we have undertaken a systematic review of studies of co-infected prisoners to determine the incidence and/or prevalence of HIV/TB co-infection in prisons, as well as outcomes in this group, measured as treatment success or death.

Methods: A literature search was undertaken using the online databases PubMed, Embase, IBSS, Scopus, Web of Science, Global Health and CINAHL Plus. No restrictions were set on language or publication date for article retrieval, with articles included if indexed up to 18 October 2015. A total of 1975 non-duplicate papers were identified. For treatment and outcome data all eligible papers were appraised for inclusion; for incidence/prevalence estimates papers published prior to 2000 were excluded from full text review. After full text appraisal, 46 papers were selected for inclusion in the review, 41 for incidence/prevalence estimates and nine for outcomes data, with four papers providing evidence for both outcomes and prevalence/incidence.

Results: Very few studies estimated the incidence of TB in HIV positive prisoners, with most simply reporting prevalence of co-infection. Co-infection is rarely explicitly measured, with studies simply reporting HIV status in prisoners with TB, or a cross-sectional survey of TB prevalence amongst prisoners with HIV. Estimates of co-infection prevalence ranged from 2.4 to 73.1% and relative risks for one, given the other, ranged from 2.0 to 10.75, although some studies reported no significant association between HIV and TB. Few studies provided a comparison with the risk of co-infection in the general population.

Conclusions: Prisoners infected with HIV are at high risk of developing TB. However, the magnitude of risk varies between different prisons and countries. There is little evidence on treatment outcomes in co-infected prisoners, and the existing evidence is conflicting in regards to HIV status influence on prisoner treatment outcomes.PROSPERO Number: CRD42016034068.

Citing Articles

Examining risk factors for HIV infection amongst male inmates in Peruvian prisons: a cross-sectional study using national prisoner census data.

Quispe-Canari J, Carrasco-Navarro R Rev Esp Sanid Penit. 2025; 26(3):82-91.

PMID: 39927805 PMC: 11632554. DOI: 10.18176/resp.00093.


Prevalence and associated factors of TB and HIV coinfections among adult inmates with presumptive pulmonary TB in a Kenyan prison.

Mwatenga S, Musa A, Muturi M, Musyoki A Trop Med Health. 2024; 52(1):54.

PMID: 39148132 PMC: 11328499. DOI: 10.1186/s41182-024-00623-2.


Prevalence, treatment outcomes and determinants of TB/HIV coinfection: A 4-year retrospective review of national tuberculosis registry in a country in a MENA region.

Kazemian S, Shakeri M, Nazar E, Nasehi M, Sharafi S, Dadgarmoghaddam M Heliyon. 2024; 10(5):e26615.

PMID: 38434388 PMC: 10904239. DOI: 10.1016/j.heliyon.2024.e26615.


Prevalence of Tuberculosis among People Who Use Drugs in Iran: A Systematic Review and Meta-analysis.

Rafiemanesh H, Shadloo B, Amin-Esmaeili M, Rahimi Y, Gholami J, Rahimi-Movaghar A Addict Health. 2023; 15(3):219-227.

PMID: 38026719 PMC: 10658100. DOI: 10.34172/ahj.2023.1399.


Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews.

Litvinjenko S, Magwood O, Wu S, Wei X Lancet Infect Dis. 2023; 23(12):1395-1407.

PMID: 37696278 PMC: 10665202. DOI: 10.1016/S1473-3099(23)00372-9.


References
1.
Sanchez A, Gerhardt G, Natal S, Capone D, Espinola A, Costa W . Prevalence of pulmonary tuberculosis and comparative evaluation of screening strategies in a Brazilian prison. Int J Tuberc Lung Dis. 2005; 9(6):633-9. View

2.
Romero Saldana M, Vaquero Abellan M, Gallego Rubio R, Aguilera Lopez M, de Celis Cornejo J, Barquin Garcia E . [Evaluation of compliance with antituberculous chemoprophylaxis among recluse population of the Jaen penitentiary center]. Rev Esp Salud Publica. 1997; 71(4):391-9. View

3.
Dolan K, Wirtz A, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner S . Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016; 388(10049):1089-1102. DOI: 10.1016/S0140-6736(16)30466-4. View

4.
Winetsky D, Almukhamedov O, Pulatov D, Vezhnina N, Dooronbekova A, Zhussupov B . Prevalence, risk factors and social context of active pulmonary tuberculosis among prison inmates in Tajikistan. PLoS One. 2014; 9(1):e86046. PMC: 3896449. DOI: 10.1371/journal.pone.0086046. View

5.
Makombe S, Jahn A, Tweya H, Thambo L, Yu J, Hedt B . A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy. J Infect Dev Ctries. 2009; 1(3):303-7. View